Children and adolescents (aged 13 to 17 years) Polyarticular Juvenile Idiopathic Arthritis The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 13 years and above is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection.